BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12020494)

  • 21. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-type natriuretic peptide and clinical judgment in the detection of exercise-induced myocardial ischemia.
    Lee G; Sou SM; Twerenbold R; Reichlin T; Oshima S; Hochgruber T; Zürcher S; Matter D; Tanglay Y; Freese M; Honegger U; Wild D; Rentsch K; Osswald S; Zellweger MJ; Mueller C
    Am J Med; 2014 May; 127(5):427-35. PubMed ID: 24486287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction.
    Matsumoto A; Hirata Y; Momomura S; Suzuki E; Yokoyama I; Sata M; Ohtani Y; Serizawa T
    Am Heart J; 1995 Jan; 129(1):139-45. PubMed ID: 7817907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy.
    Mizuno Y; Yoshimura M; Harada E; Nakayama M; Sakamoto T; Shimasaki Y; Ogawa H; Kugiyama K; Saito Y; Nakao K; Yasue H
    Am J Cardiol; 2000 Nov; 86(9):1036-40, A11. PubMed ID: 11053725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of tissue Doppler imaging to predict exercise capacity in hypertrophic cardiomyopathy: comparison with B-type natriuretic peptide.
    Kitaoka H; Kubo T; Okawa M; Hirota T; Hayato K; Yamasaki N; Matsumura Y; Doi YL
    J Cardiol; 2009 Jun; 53(3):361-7. PubMed ID: 19477377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incremental value of left ventricular diastolic function reserve index for predicting exercise capacity in patients with hypertrophic cardiomyopathy.
    Choi EY; Ha JW; Rim SJ; Kim SA; Yoon SJ; Shim CY; Kim JM; Jang Y; Chung N; Cho SY
    J Am Soc Echocardiogr; 2008 May; 21(5):487-92. PubMed ID: 17904804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure.
    Bentzen H; Pedersen RS; Nyvad O; Pedersen EB
    Int J Cardiol; 2004 Feb; 93(2-3):121-30. PubMed ID: 14975537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemistry of atrial and brain natriuretic peptides in control cats and cats with hypertrophic cardiomyopathy.
    Biondo AW; Ehrhart EJ; Sisson DD; Bulmer BJ; De Morais HS; Solter PF
    Vet Pathol; 2003 Sep; 40(5):501-6. PubMed ID: 12949406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resting ST-segment depression predicts exercise-induced subendocardial ischemia in patients with hypertrophic cardiomyopathy.
    Kawasaki T; Azuma A; Kuribayashi T; Taniguchi T; Miyai N; Kamitani T; Kawasaki S; Matsubara H; Sugihara H
    Int J Cardiol; 2006 Feb; 107(2):267-74. PubMed ID: 16412807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload.
    Hirata Y; Matsumoto A; Aoyagi T; Yamaoki K; Komuro I; Suzuki T; Ashida T; Sugiyama T; Hada Y; Kuwajima I; Nishinaga M; Akioka H; Nakajima O; Nagai R; Yazaki Y
    Cardiovasc Res; 2001 Aug; 51(3):585-91. PubMed ID: 11476749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
    Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
    Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock.
    Ueda S; Nishio K; Akai Y; Fukushima H; Ueyama T; Kawai Y; Masui K; Yoshioka A; Okuchi K
    Shock; 2006 Aug; 26(2):134-9. PubMed ID: 16878020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia.
    Asada J; Tsuji H; Iwasaka T; Thomas JD; Lauer MS
    Am J Cardiol; 2004 Mar; 93(6):702-4. PubMed ID: 15019872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac natriuretic peptides after myocardial infarction: relationship with infarct size, left ventricular function and remodelling assessed by 99mTc-sestamibi gated-single photon emission tomography.
    Ceriani L; Giovanella L
    Clin Chem Lab Med; 2007; 45(2):226-31. PubMed ID: 17311513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise.
    Friedl W; Mair J; Thomas S; Pichler M; Puschendorf B
    Clin Chim Acta; 1999 Mar; 281(1-2):121-6. PubMed ID: 10217633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma endothelin-1 level in chronic obstructive pulmonary disease: relationship with natriuretic peptide.
    Fujii T; Otsuka T; Tanaka S; Kanazawa H; Hirata K; Kohno M; Kurihara N; Yoshikawa J
    Respiration; 1999; 66(3):212-9. PubMed ID: 10364736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation.
    Yamada T; Murakami Y; Okada T; Okamoto M; Shimizu T; Toyama J; Yoshida Y; Tsuboi N; Ito T; Muto M; Kondo T; Inden Y; Hirai M; Murohara T
    Am J Cardiol; 2006 Jun; 97(12):1741-4. PubMed ID: 16765125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-type natriuretic peptide and outcome in patients with apical hypertrophic cardiomyopathy.
    Shirotani S; Minami Y; Saito C; Haruki S; Hagiwara N
    J Cardiol; 2020 Oct; 76(4):357-363. PubMed ID: 32439341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides.
    Foote RS; Pearlman JD; Siegel AH; Yeo KT
    J Am Coll Cardiol; 2004 Nov; 44(10):1980-7. PubMed ID: 15542280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.